Inflammasome activation contributes to interleukin-23 production in response to Clostridium difficile.
about
Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal EffectsThe binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia.Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection.The microbiota and immune response during Clostridium difficile infection.Understanding the mechanisms of faecal microbiota transplantation.Clostridium difficile colitis: pathogenesis and host defenceEpidemiology of Clostridium difficile Infection-Associated Reactive Arthritis in Children: An Underdiagnosed, Potentially Morbid Condition.Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity.Pathogenic effects of glucosyltransferase from Clostridium difficile toxins.Host response to Clostridium difficile infection: Diagnostics and detection.Interleukin-23 (IL-23), independent of IL-17 and IL-22, drives neutrophil recruitment and innate inflammation during Clostridium difficile colitis in mice.Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic Molecules.The role of toxins in Clostridium difficile infection.Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes.FECAL HOST TRANSCRIPTOMICS FOR NON-INVASIVE HUMAN MUCOSAL IMMUNE PROFILING: PROOF OF CONCEPT IN INFECTIONSystemic Inflammatory Responses in Ulcerative Colitis Patients and Clostridium difficile Infection
P2860
Q26751477-5EE85DF1-FA6A-48F8-B57D-3BB804D8475CQ30276036-0F0FB290-BC42-4CD8-8B5F-80AC749536B4Q30276498-103662AF-F635-4976-93C9-5D14E2772800Q30276756-D1B54BF2-88C9-49F4-9234-BC902AE5F8BFQ36058419-9AAE9E23-95A7-495E-81C4-F3F0065B4FB5Q36116428-A6A93348-0141-4044-A54B-EFBDADAED614Q37348209-D53C78B0-65E5-4176-A598-5EFFD9B733B9Q38737485-6802F344-384C-46AF-B3A3-3DCC11444976Q38797967-CC39FAED-06D2-4580-925C-CFFC416F6A23Q38969987-F0A6A44D-3CE5-4E52-9F0E-AE87D361F632Q40444654-F36F1835-8AF4-4468-BC6E-552E21A15E39Q47162429-F5539ABC-2361-44B3-A3E5-805507CCDB1BQ47734724-EEFC007F-DC8E-4381-9031-8CF6AB44EE37Q49841486-84F49008-AB9D-445C-A0D6-FB9F3BB3FAD3Q50026548-47C1937A-DC7F-40B1-BB1D-0D64447FCEEDQ57150262-6629DE09-6091-4C25-9D7F-3EDDF781035EQ57177958-0D59E1F2-0C15-495F-84F9-4D794D92797A
P2860
Inflammasome activation contributes to interleukin-23 production in response to Clostridium difficile.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Inflammasome activation contri ...... onse to Clostridium difficile.
@ast
Inflammasome activation contri ...... onse to Clostridium difficile.
@en
type
label
Inflammasome activation contri ...... onse to Clostridium difficile.
@ast
Inflammasome activation contri ...... onse to Clostridium difficile.
@en
prefLabel
Inflammasome activation contri ...... onse to Clostridium difficile.
@ast
Inflammasome activation contri ...... onse to Clostridium difficile.
@en
P2093
P2860
P50
P356
P1433
P1476
Inflammasome activation contri ...... onse to Clostridium difficile.
@en
P2093
Chelsea S Marie
Erica L Buonomo
Sarah A Kuehne
P2860
P356
10.1128/MBIO.02386-14
P577
2015-01-27T00:00:00Z